Tarsus Pharmaceuticals, Inc.
Ticker: 1819790
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 162.05+36.5% | 118.70+15.6% | 102.66+31.0% | 78.34+62.8% | 48.12+17.9% | 40.81+47.8% | 27.61+1376.5% | 1.87 |
| Total Income | 162.05+36.5% | 118.70+15.6% | 102.66+31.0% | 78.34+62.8% | 48.12+17.9% | 40.81+47.8% | 27.61+1376.5% | 1.87 |
| EXPENSES | ||||||||
| Expenditure | 168.18+26.2% | 133.23+6.7% | 124.84+19.3% | 104.62+42.8% | 73.28-1.1% | 74.12+13.5% | 65.30+52.5% | 42.81 |
| Tax | 2.35 | — | — | — | — | — | — | 0.00 |
| PROFIT | ||||||||
| Net Profit | -6.97+44.6% | -12.59+38.1% | -20.34+19.0% | -25.12-7.3% | -23.42+29.6% | -33.29+6.8% | -35.73+8.7% | -39.15 |
| KEY METRICS | ||||||||
| OPM % | -3.78%+8.46pp | -12.24%+9.37pp | -21.61%+11.94pp | -33.55%+18.74pp | -52.29%+29.30pp | -81.60%+18.40pp | -100.00% | -100.00% |
| NPM % | -4.30%+6.30pp | -10.60%+9.21pp | -19.81%+12.25pp | -32.07%+16.60pp | -48.67%+32.89pp | -81.57%+18.43pp | -100.00% | -100.00% |
| EPS | -0.16+46.7% | -0.30+37.5% | -0.48+25.0% | -0.64-4.9% | -0.61+30.7% | -0.88+12.9% | -1.01+21.1% | -1.28 |
Corporate Events
Board MeetingTARS
202615Jul
Board Meeting
Aziz Mottiwala to depart as Chief Commercial Officer of Tars…
SEC Filing ↗ Board MeetingTARS
202625Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve e…
SEC Filing ↗